A shift away from traditional prescribing decision-making

摘要

Political uncertainty notwithstanding, the NHS looks set for serious change as senior managers wrestle the budgeting challenges that must be imposed in response to the global economic problems. However, for pharmaceutical companies, changes in the NHS will have far greater implications than the need to identify a new set of key opinion leaders.